nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ABCG2—Vismodegib—skin cancer	0.0666	0.0933	CbGbCtD
Tamoxifen—ABCG2—Vemurafenib—skin cancer	0.0527	0.0738	CbGbCtD
Tamoxifen—CYP1A2—Imiquimod—skin cancer	0.0396	0.0555	CbGbCtD
Tamoxifen—CYP1B1—Docetaxel—skin cancer	0.038	0.0533	CbGbCtD
Tamoxifen—CYP1A1—Dacarbazine—skin cancer	0.0373	0.0522	CbGbCtD
Tamoxifen—CYP2C8—Vismodegib—skin cancer	0.0355	0.0497	CbGbCtD
Tamoxifen—ABCG2—Dactinomycin—skin cancer	0.035	0.049	CbGbCtD
Tamoxifen—CYP2C19—Vismodegib—skin cancer	0.0298	0.0417	CbGbCtD
Tamoxifen—CYP2E1—Dacarbazine—skin cancer	0.0288	0.0403	CbGbCtD
Tamoxifen—CYP2A6—Fluorouracil—skin cancer	0.0256	0.0358	CbGbCtD
Tamoxifen—CYP2C9—Vismodegib—skin cancer	0.0248	0.0347	CbGbCtD
Tamoxifen—ABCB1—Vismodegib—skin cancer	0.024	0.0337	CbGbCtD
Tamoxifen—ABCG2—Fluorouracil—skin cancer	0.0237	0.0332	CbGbCtD
Tamoxifen—CYP1A2—Vemurafenib—skin cancer	0.0217	0.0304	CbGbCtD
Tamoxifen—CYP3A4—Temozolomide—skin cancer	0.0208	0.0291	CbGbCtD
Tamoxifen—CYP3A4—Imiquimod—skin cancer	0.0208	0.0291	CbGbCtD
Tamoxifen—ABCC2—Docetaxel—skin cancer	0.02	0.028	CbGbCtD
Tamoxifen—ABCG2—Docetaxel—skin cancer	0.0181	0.0253	CbGbCtD
Tamoxifen—CYP2D6—Vemurafenib—skin cancer	0.0179	0.0251	CbGbCtD
Tamoxifen—CYP1A2—Dacarbazine—skin cancer	0.0166	0.0233	CbGbCtD
Tamoxifen—CYP3A4—Vismodegib—skin cancer	0.0144	0.0202	CbGbCtD
Tamoxifen—CYP3A7—Docetaxel—skin cancer	0.0134	0.0187	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0134	0.0187	CbGbCtD
Tamoxifen—ABCB1—Dactinomycin—skin cancer	0.0126	0.0177	CbGbCtD
Tamoxifen—CYP2C8—Fluorouracil—skin cancer	0.0126	0.0177	CbGbCtD
Tamoxifen—CYP3A4—Vemurafenib—skin cancer	0.0114	0.0159	CbGbCtD
Tamoxifen—CYP3A5—Docetaxel—skin cancer	0.01	0.014	CbGbCtD
Tamoxifen—CYP1A2—Fluorouracil—skin cancer	0.00976	0.0137	CbGbCtD
Tamoxifen—CYP2C9—Fluorouracil—skin cancer	0.00879	0.0123	CbGbCtD
Tamoxifen—ABCB1—Docetaxel—skin cancer	0.00652	0.00913	CbGbCtD
Tamoxifen—CYP3A4—Docetaxel—skin cancer	0.00391	0.00547	CbGbCtD
Tamoxifen—EBP—Sorafenib—Vismodegib—skin cancer	0.00321	1	CbGdCrCtD
Tamoxifen—DHCR7—hair follicle—skin cancer	0.00272	0.0448	CbGeAlD
Tamoxifen—SULT1A1—neck—skin cancer	0.00257	0.0423	CbGeAlD
Tamoxifen—EBPL—epithelium—skin cancer	0.0022	0.0362	CbGeAlD
Tamoxifen—DHCR7—nipple—skin cancer	0.00185	0.0304	CbGeAlD
Tamoxifen—ESRRA—nipple—skin cancer	0.00182	0.0299	CbGeAlD
Tamoxifen—EBP—female reproductive system—skin cancer	0.00157	0.0258	CbGeAlD
Tamoxifen—EBPL—head—skin cancer	0.00137	0.0225	CbGeAlD
Tamoxifen—SULT1A1—female reproductive system—skin cancer	0.0013	0.0214	CbGeAlD
Tamoxifen—CES1—neck—skin cancer	0.00125	0.0205	CbGeAlD
Tamoxifen—CYP1B1—hair follicle—skin cancer	0.00119	0.0195	CbGeAlD
Tamoxifen—DHCR7—skin of body—skin cancer	0.00118	0.0195	CbGeAlD
Tamoxifen—CYP1A1—skin epidermis—skin cancer	0.00117	0.0193	CbGeAlD
Tamoxifen—SULT1A1—head—skin cancer	0.00108	0.0179	CbGeAlD
Tamoxifen—ESR2—neck—skin cancer	0.00108	0.0178	CbGeAlD
Tamoxifen—DHCR7—mammalian vulva—skin cancer	0.00108	0.0178	CbGeAlD
Tamoxifen—FMO1—mammalian vulva—skin cancer	0.00108	0.0178	CbGeAlD
Tamoxifen—ESRRA—mammalian vulva—skin cancer	0.00106	0.0175	CbGeAlD
Tamoxifen—ESR1—blood vessel—skin cancer	0.00103	0.017	CbGeAlD
Tamoxifen—DHCR7—lymphoid tissue—skin cancer	0.000958	0.0158	CbGeAlD
Tamoxifen—EBPL—lymph node—skin cancer	0.000956	0.0157	CbGeAlD
Tamoxifen—FMO3—mammalian vulva—skin cancer	0.000932	0.0153	CbGeAlD
Tamoxifen—DHCR7—female reproductive system—skin cancer	0.000924	0.0152	CbGeAlD
Tamoxifen—ESRRA—female reproductive system—skin cancer	0.000909	0.015	CbGeAlD
Tamoxifen—CES1—connective tissue—skin cancer	0.000894	0.0147	CbGeAlD
Tamoxifen—SIGMAR1—nipple—skin cancer	0.000845	0.0139	CbGeAlD
Tamoxifen—ESR2—connective tissue—skin cancer	0.000774	0.0127	CbGeAlD
Tamoxifen—DHCR7—head—skin cancer	0.000772	0.0127	CbGeAlD
Tamoxifen—FMO1—head—skin cancer	0.000772	0.0127	CbGeAlD
Tamoxifen—SULT1A1—lymph node—skin cancer	0.00076	0.0125	CbGeAlD
Tamoxifen—ESRRA—head—skin cancer	0.00076	0.0125	CbGeAlD
Tamoxifen—ESR1—neck—skin cancer	0.000739	0.0122	CbGeAlD
Tamoxifen—ESR2—epithelium—skin cancer	0.000735	0.0121	CbGeAlD
Tamoxifen—FMO3—head—skin cancer	0.000667	0.011	CbGeAlD
Tamoxifen—CES1—lymphoid tissue—skin cancer	0.000653	0.0108	CbGeAlD
Tamoxifen—CES1—female reproductive system—skin cancer	0.00063	0.0104	CbGeAlD
Tamoxifen—CYP19A1—connective tissue—skin cancer	0.00061	0.01	CbGeAlD
Tamoxifen—CYP1A2—nipple—skin cancer	0.000576	0.00948	CbGeAlD
Tamoxifen—CYP1B1—connective tissue—skin cancer	0.00057	0.00938	CbGeAlD
Tamoxifen—CYP1A1—nipple—skin cancer	0.000568	0.00935	CbGeAlD
Tamoxifen—ESR2—lymphoid tissue—skin cancer	0.000566	0.00931	CbGeAlD
Tamoxifen—ESR2—female reproductive system—skin cancer	0.000546	0.00898	CbGeAlD
Tamoxifen—DHCR7—lymph node—skin cancer	0.00054	0.00889	CbGeAlD
Tamoxifen—FMO1—lymph node—skin cancer	0.00054	0.00889	CbGeAlD
Tamoxifen—ESRRA—lymph node—skin cancer	0.000532	0.00875	CbGeAlD
Tamoxifen—ESR1—connective tissue—skin cancer	0.00053	0.00872	CbGeAlD
Tamoxifen—CES1—head—skin cancer	0.000526	0.00867	CbGeAlD
Tamoxifen—CYP1B1—skin of body—skin cancer	0.000515	0.00847	CbGeAlD
Tamoxifen—ESR1—epithelium—skin cancer	0.000503	0.00828	CbGeAlD
Tamoxifen—SIGMAR1—mammalian vulva—skin cancer	0.000494	0.00813	CbGeAlD
Tamoxifen—FMO3—lymph node—skin cancer	0.000467	0.00769	CbGeAlD
Tamoxifen—ESR2—head—skin cancer	0.000456	0.0075	CbGeAlD
Tamoxifen—CYP19A1—female reproductive system—skin cancer	0.00043	0.00708	CbGeAlD
Tamoxifen—CYP1B1—lymphoid tissue—skin cancer	0.000417	0.00686	CbGeAlD
Tamoxifen—ABCC2—female reproductive system—skin cancer	0.00041	0.00676	CbGeAlD
Tamoxifen—ABCB1—blood vessel—skin cancer	0.000408	0.00672	CbGeAlD
Tamoxifen—CYP1B1—female reproductive system—skin cancer	0.000402	0.00662	CbGeAlD
Tamoxifen—ESR1—lymphoid tissue—skin cancer	0.000387	0.00638	CbGeAlD
Tamoxifen—CYP1A1—epithelium—skin cancer	0.000383	0.0063	CbGeAlD
Tamoxifen—ESR1—female reproductive system—skin cancer	0.000374	0.00615	CbGeAlD
Tamoxifen—CES1—lymph node—skin cancer	0.000369	0.00607	CbGeAlD
Tamoxifen—CYP1A1—skin of body—skin cancer	0.000364	0.00599	CbGeAlD
Tamoxifen—CYP19A1—head—skin cancer	0.000359	0.00591	CbGeAlD
Tamoxifen—CYP2B6—skin of body—skin cancer	0.000354	0.00582	CbGeAlD
Tamoxifen—ABCG2—mammalian vulva—skin cancer	0.00035	0.00575	CbGeAlD
Tamoxifen—CYP1B1—head—skin cancer	0.000336	0.00553	CbGeAlD
Tamoxifen—CYP1A1—mammalian vulva—skin cancer	0.000332	0.00546	CbGeAlD
Tamoxifen—ESR2—lymph node—skin cancer	0.000319	0.00525	CbGeAlD
Tamoxifen—ESR1—head—skin cancer	0.000312	0.00514	CbGeAlD
Tamoxifen—CYP2C8—female reproductive system—skin cancer	0.000308	0.00507	CbGeAlD
Tamoxifen—Angina pectoris—Fluorouracil—skin cancer	0.000288	0.00137	CcSEcCtD
Tamoxifen—Pneumonia—Temozolomide—skin cancer	0.000288	0.00137	CcSEcCtD
Tamoxifen—CYP2B6—lymphoid tissue—skin cancer	0.000286	0.00471	CbGeAlD
Tamoxifen—Depression—Temozolomide—skin cancer	0.000285	0.00136	CcSEcCtD
Tamoxifen—CYP1A1—female reproductive system—skin cancer	0.000284	0.00468	CbGeAlD
Tamoxifen—Hepatitis—Dactinomycin—skin cancer	0.000284	0.00135	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000283	0.00135	CcSEcCtD
Tamoxifen—Flushing—Bleomycin—skin cancer	0.000282	0.00135	CcSEcCtD
Tamoxifen—Pharyngitis—Dactinomycin—skin cancer	0.000282	0.00134	CcSEcCtD
Tamoxifen—Pancytopenia—Fluorouracil—skin cancer	0.000281	0.00134	CcSEcCtD
Tamoxifen—Swelling—Docetaxel—skin cancer	0.00028	0.00133	CcSEcCtD
Tamoxifen—Urinary tract infection—Temozolomide—skin cancer	0.000278	0.00133	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000277	0.00132	CcSEcCtD
Tamoxifen—CYP2B6—female reproductive system—skin cancer	0.000276	0.00455	CbGeAlD
Tamoxifen—Insomnia—Imiquimod—skin cancer	0.000275	0.00131	CcSEcCtD
Tamoxifen—Hepatic failure—Docetaxel—skin cancer	0.000275	0.00131	CcSEcCtD
Tamoxifen—CYP2C9—female reproductive system—skin cancer	0.000273	0.0045	CbGeAlD
Tamoxifen—Paraesthesia—Imiquimod—skin cancer	0.000273	0.0013	CcSEcCtD
Tamoxifen—Dyspnoea—Imiquimod—skin cancer	0.000271	0.00129	CcSEcCtD
Tamoxifen—Alopecia—Bleomycin—skin cancer	0.000269	0.00128	CcSEcCtD
Tamoxifen—CYP2E1—lymphoid tissue—skin cancer	0.000269	0.00442	CbGeAlD
Tamoxifen—Erythema multiforme—Dactinomycin—skin cancer	0.000268	0.00128	CcSEcCtD
Tamoxifen—Sinusitis—Temozolomide—skin cancer	0.000268	0.00128	CcSEcCtD
Tamoxifen—Dyspepsia—Imiquimod—skin cancer	0.000268	0.00128	CcSEcCtD
Tamoxifen—Pneumonia—Fluorouracil—skin cancer	0.000265	0.00126	CcSEcCtD
Tamoxifen—Erythema—Bleomycin—skin cancer	0.000265	0.00126	CcSEcCtD
Tamoxifen—Decreased appetite—Imiquimod—skin cancer	0.000264	0.00126	CcSEcCtD
Tamoxifen—Hot flush—Docetaxel—skin cancer	0.000264	0.00126	CcSEcCtD
Tamoxifen—Flushing—Dactinomycin—skin cancer	0.000263	0.00126	CcSEcCtD
Tamoxifen—Hypersensitivity—Vemurafenib—skin cancer	0.000263	0.00125	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Imiquimod—skin cancer	0.000263	0.00125	CcSEcCtD
Tamoxifen—Fatigue—Imiquimod—skin cancer	0.000262	0.00125	CcSEcCtD
Tamoxifen—Menopausal symptoms—Docetaxel—skin cancer	0.000261	0.00125	CcSEcCtD
Tamoxifen—Visual disturbance—Docetaxel—skin cancer	0.00026	0.00124	CcSEcCtD
Tamoxifen—Pain—Imiquimod—skin cancer	0.00026	0.00124	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Fluorouracil—skin cancer	0.00026	0.00124	CcSEcCtD
Tamoxifen—CYP2E1—female reproductive system—skin cancer	0.000259	0.00427	CbGeAlD
Tamoxifen—Myocardial infarction—Fluorouracil—skin cancer	0.000258	0.00123	CcSEcCtD
Tamoxifen—Dermatitis bullous—Docetaxel—skin cancer	0.000258	0.00123	CcSEcCtD
Tamoxifen—Haemoglobin—Temozolomide—skin cancer	0.000258	0.00123	CcSEcCtD
Tamoxifen—Hepatitis—Temozolomide—skin cancer	0.000257	0.00122	CcSEcCtD
Tamoxifen—Haemorrhage—Temozolomide—skin cancer	0.000257	0.00122	CcSEcCtD
Tamoxifen—Urinary tract infection—Fluorouracil—skin cancer	0.000256	0.00122	CcSEcCtD
Tamoxifen—Asthenia—Vemurafenib—skin cancer	0.000256	0.00122	CcSEcCtD
Tamoxifen—Hypoaesthesia—Temozolomide—skin cancer	0.000255	0.00122	CcSEcCtD
Tamoxifen—Pharyngitis—Temozolomide—skin cancer	0.000255	0.00122	CcSEcCtD
Tamoxifen—Oedema peripheral—Temozolomide—skin cancer	0.000253	0.00121	CcSEcCtD
Tamoxifen—Pruritus—Vemurafenib—skin cancer	0.000252	0.0012	CcSEcCtD
Tamoxifen—CYP19A1—lymph node—skin cancer	0.000252	0.00414	CbGeAlD
Tamoxifen—Alopecia—Dactinomycin—skin cancer	0.000251	0.0012	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Imiquimod—skin cancer	0.000249	0.00119	CcSEcCtD
Tamoxifen—SIGMAR1—lymph node—skin cancer	0.000247	0.00407	CbGeAlD
Tamoxifen—Visual impairment—Temozolomide—skin cancer	0.000247	0.00118	CcSEcCtD
Tamoxifen—Sinusitis—Fluorouracil—skin cancer	0.000247	0.00118	CcSEcCtD
Tamoxifen—Erythema—Dactinomycin—skin cancer	0.000247	0.00118	CcSEcCtD
Tamoxifen—Anaemia—Bleomycin—skin cancer	0.000245	0.00117	CcSEcCtD
Tamoxifen—Diarrhoea—Vemurafenib—skin cancer	0.000244	0.00116	CcSEcCtD
Tamoxifen—Erythema multiforme—Temozolomide—skin cancer	0.000243	0.00116	CcSEcCtD
Tamoxifen—Urticaria—Imiquimod—skin cancer	0.000242	0.00115	CcSEcCtD
Tamoxifen—Abdominal pain—Imiquimod—skin cancer	0.000241	0.00115	CcSEcCtD
Tamoxifen—ABCC2—lymph node—skin cancer	0.00024	0.00395	CbGeAlD
Tamoxifen—Flushing—Temozolomide—skin cancer	0.000238	0.00114	CcSEcCtD
Tamoxifen—Haemoglobin—Fluorouracil—skin cancer	0.000238	0.00113	CcSEcCtD
Tamoxifen—CYP1A1—head—skin cancer	0.000237	0.00391	CbGeAlD
Tamoxifen—Leukopenia—Bleomycin—skin cancer	0.000237	0.00113	CcSEcCtD
Tamoxifen—Haemorrhage—Fluorouracil—skin cancer	0.000236	0.00113	CcSEcCtD
Tamoxifen—Dizziness—Vemurafenib—skin cancer	0.000236	0.00113	CcSEcCtD
Tamoxifen—Hypoaesthesia—Fluorouracil—skin cancer	0.000235	0.00112	CcSEcCtD
Tamoxifen—CYP1B1—lymph node—skin cancer	0.000235	0.00387	CbGeAlD
Tamoxifen—Pharyngitis—Fluorouracil—skin cancer	0.000235	0.00112	CcSEcCtD
Tamoxifen—Cough—Bleomycin—skin cancer	0.000231	0.0011	CcSEcCtD
Tamoxifen—CYP2B6—head—skin cancer	0.000231	0.0038	CbGeAlD
Tamoxifen—Anaemia—Dactinomycin—skin cancer	0.000228	0.00109	CcSEcCtD
Tamoxifen—Liver function test abnormal—Docetaxel—skin cancer	0.000228	0.00109	CcSEcCtD
Tamoxifen—Vomiting—Vemurafenib—skin cancer	0.000227	0.00108	CcSEcCtD
Tamoxifen—Alopecia—Temozolomide—skin cancer	0.000227	0.00108	CcSEcCtD
Tamoxifen—Myalgia—Bleomycin—skin cancer	0.000225	0.00108	CcSEcCtD
Tamoxifen—Chest pain—Bleomycin—skin cancer	0.000225	0.00108	CcSEcCtD
Tamoxifen—Rash—Vemurafenib—skin cancer	0.000225	0.00107	CcSEcCtD
Tamoxifen—Dermatitis—Vemurafenib—skin cancer	0.000225	0.00107	CcSEcCtD
Tamoxifen—Hypersensitivity—Imiquimod—skin cancer	0.000224	0.00107	CcSEcCtD
Tamoxifen—Headache—Vemurafenib—skin cancer	0.000223	0.00107	CcSEcCtD
Tamoxifen—Erythema—Temozolomide—skin cancer	0.000223	0.00107	CcSEcCtD
Tamoxifen—Discomfort—Bleomycin—skin cancer	0.000223	0.00106	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000222	0.00106	CcSEcCtD
Tamoxifen—Cramp muscle—Docetaxel—skin cancer	0.000222	0.00106	CcSEcCtD
Tamoxifen—Leukopenia—Dactinomycin—skin cancer	0.000221	0.00106	CcSEcCtD
Tamoxifen—Dysgeusia—Temozolomide—skin cancer	0.000219	0.00104	CcSEcCtD
Tamoxifen—ESR1—lymph node—skin cancer	0.000219	0.0036	CbGeAlD
Tamoxifen—Asthenia—Imiquimod—skin cancer	0.000218	0.00104	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000218	0.00104	CcSEcCtD
Tamoxifen—CYP2E1—head—skin cancer	0.000217	0.00356	CbGeAlD
Tamoxifen—Oedema—Bleomycin—skin cancer	0.000216	0.00103	CcSEcCtD
Tamoxifen—Back pain—Temozolomide—skin cancer	0.000216	0.00103	CcSEcCtD
Tamoxifen—Pruritus—Imiquimod—skin cancer	0.000215	0.00103	CcSEcCtD
Tamoxifen—Infection—Bleomycin—skin cancer	0.000215	0.00102	CcSEcCtD
Tamoxifen—Dysphagia—Docetaxel—skin cancer	0.000213	0.00102	CcSEcCtD
Tamoxifen—Nausea—Vemurafenib—skin cancer	0.000212	0.00101	CcSEcCtD
Tamoxifen—Thrombocytopenia—Bleomycin—skin cancer	0.000212	0.00101	CcSEcCtD
Tamoxifen—Arrhythmia—Fluorouracil—skin cancer	0.000211	0.00101	CcSEcCtD
Tamoxifen—Myalgia—Dactinomycin—skin cancer	0.00021	0.001	CcSEcCtD
Tamoxifen—Alopecia—Fluorouracil—skin cancer	0.000209	0.000997	CcSEcCtD
Tamoxifen—CYP3A4—female reproductive system—skin cancer	0.000209	0.00343	CbGeAlD
Tamoxifen—Diarrhoea—Imiquimod—skin cancer	0.000208	0.000993	CcSEcCtD
Tamoxifen—Discomfort—Dactinomycin—skin cancer	0.000208	0.000992	CcSEcCtD
Tamoxifen—Angina pectoris—Docetaxel—skin cancer	0.000208	0.000991	CcSEcCtD
Tamoxifen—Anaemia—Temozolomide—skin cancer	0.000206	0.000985	CcSEcCtD
Tamoxifen—Anorexia—Bleomycin—skin cancer	0.000206	0.000983	CcSEcCtD
Tamoxifen—Erythema—Fluorouracil—skin cancer	0.000206	0.000982	CcSEcCtD
Tamoxifen—CYP2D6—female reproductive system—skin cancer	0.000205	0.00338	CbGeAlD
Tamoxifen—Angioedema—Temozolomide—skin cancer	0.000204	0.000974	CcSEcCtD
Tamoxifen—Pancytopenia—Docetaxel—skin cancer	0.000202	0.000966	CcSEcCtD
Tamoxifen—Oedema—Dactinomycin—skin cancer	0.000202	0.000962	CcSEcCtD
Tamoxifen—Dizziness—Imiquimod—skin cancer	0.000201	0.00096	CcSEcCtD
Tamoxifen—Infection—Dactinomycin—skin cancer	0.0002	0.000956	CcSEcCtD
Tamoxifen—Leukopenia—Temozolomide—skin cancer	0.0002	0.000954	CcSEcCtD
Tamoxifen—Neutropenia—Docetaxel—skin cancer	0.000199	0.000951	CcSEcCtD
Tamoxifen—ABCB1—epithelium—skin cancer	0.000199	0.00327	CbGeAlD
Tamoxifen—Thrombocytopenia—Dactinomycin—skin cancer	0.000197	0.000942	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000197	0.00094	CcSEcCtD
Tamoxifen—Cough—Temozolomide—skin cancer	0.000195	0.00093	CcSEcCtD
Tamoxifen—Paraesthesia—Bleomycin—skin cancer	0.000194	0.000926	CcSEcCtD
Tamoxifen—Weight increased—Docetaxel—skin cancer	0.000194	0.000926	CcSEcCtD
Tamoxifen—Vomiting—Imiquimod—skin cancer	0.000193	0.000923	CcSEcCtD
Tamoxifen—Weight decreased—Docetaxel—skin cancer	0.000193	0.000921	CcSEcCtD
Tamoxifen—Hypertension—Temozolomide—skin cancer	0.000193	0.00092	CcSEcCtD
Tamoxifen—Dyspnoea—Bleomycin—skin cancer	0.000193	0.00092	CcSEcCtD
Tamoxifen—Anorexia—Dactinomycin—skin cancer	0.000192	0.000917	CcSEcCtD
Tamoxifen—Rash—Imiquimod—skin cancer	0.000192	0.000915	CcSEcCtD
Tamoxifen—Dermatitis—Imiquimod—skin cancer	0.000192	0.000915	CcSEcCtD
Tamoxifen—Pneumonia—Docetaxel—skin cancer	0.000191	0.000913	CcSEcCtD
Tamoxifen—Headache—Imiquimod—skin cancer	0.000191	0.00091	CcSEcCtD
Tamoxifen—Anaemia—Fluorouracil—skin cancer	0.00019	0.000908	CcSEcCtD
Tamoxifen—Myalgia—Temozolomide—skin cancer	0.00019	0.000908	CcSEcCtD
Tamoxifen—Arthralgia—Temozolomide—skin cancer	0.00019	0.000908	CcSEcCtD
Tamoxifen—Anxiety—Temozolomide—skin cancer	0.00019	0.000905	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000188	0.000899	CcSEcCtD
Tamoxifen—Discomfort—Temozolomide—skin cancer	0.000188	0.000897	CcSEcCtD
Tamoxifen—Decreased appetite—Bleomycin—skin cancer	0.000188	0.000897	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Docetaxel—skin cancer	0.000187	0.000894	CcSEcCtD
Tamoxifen—Myocardial infarction—Docetaxel—skin cancer	0.000186	0.000889	CcSEcCtD
Tamoxifen—Dry mouth—Temozolomide—skin cancer	0.000186	0.000888	CcSEcCtD
Tamoxifen—Pain—Bleomycin—skin cancer	0.000185	0.000882	CcSEcCtD
Tamoxifen—Leukopenia—Fluorouracil—skin cancer	0.000184	0.000879	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000184	0.000876	CcSEcCtD
Tamoxifen—Oedema—Temozolomide—skin cancer	0.000182	0.00087	CcSEcCtD
Tamoxifen—Infection—Temozolomide—skin cancer	0.000181	0.000864	CcSEcCtD
Tamoxifen—Nausea—Imiquimod—skin cancer	0.000181	0.000862	CcSEcCtD
Tamoxifen—Thrombocytopenia—Temozolomide—skin cancer	0.000179	0.000852	CcSEcCtD
Tamoxifen—Hyperhidrosis—Temozolomide—skin cancer	0.000176	0.000841	CcSEcCtD
Tamoxifen—Chest pain—Fluorouracil—skin cancer	0.000175	0.000836	CcSEcCtD
Tamoxifen—Myalgia—Fluorouracil—skin cancer	0.000175	0.000836	CcSEcCtD
Tamoxifen—Decreased appetite—Dactinomycin—skin cancer	0.000175	0.000836	CcSEcCtD
Tamoxifen—ABCG2—lymph node—skin cancer	0.000175	0.00288	CbGeAlD
Tamoxifen—Fatigue—Dactinomycin—skin cancer	0.000174	0.000829	CcSEcCtD
Tamoxifen—Anorexia—Temozolomide—skin cancer	0.000174	0.000829	CcSEcCtD
Tamoxifen—Discomfort—Fluorouracil—skin cancer	0.000173	0.000826	CcSEcCtD
Tamoxifen—Pain—Dactinomycin—skin cancer	0.000172	0.000823	CcSEcCtD
Tamoxifen—ABCB1—mammalian vulva—skin cancer	0.000172	0.00284	CbGeAlD
Tamoxifen—Urticaria—Bleomycin—skin cancer	0.000172	0.000819	CcSEcCtD
Tamoxifen—Haemoglobin—Docetaxel—skin cancer	0.000172	0.000819	CcSEcCtD
Tamoxifen—CYP2D6—head—skin cancer	0.000171	0.00282	CbGeAlD
Tamoxifen—Haemorrhage—Docetaxel—skin cancer	0.000171	0.000814	CcSEcCtD
Tamoxifen—Hepatitis—Docetaxel—skin cancer	0.000171	0.000814	CcSEcCtD
Tamoxifen—Hypoaesthesia—Docetaxel—skin cancer	0.00017	0.00081	CcSEcCtD
Tamoxifen—Pharyngitis—Docetaxel—skin cancer	0.000169	0.000808	CcSEcCtD
Tamoxifen—Oedema peripheral—Docetaxel—skin cancer	0.000168	0.000802	CcSEcCtD
Tamoxifen—Oedema—Fluorouracil—skin cancer	0.000168	0.000802	CcSEcCtD
Tamoxifen—Infection—Fluorouracil—skin cancer	0.000167	0.000796	CcSEcCtD
Tamoxifen—CYP1A1—lymph node—skin cancer	0.000166	0.00274	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000166	0.000793	CcSEcCtD
Tamoxifen—Insomnia—Temozolomide—skin cancer	0.000165	0.000787	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dactinomycin—skin cancer	0.000165	0.000787	CcSEcCtD
Tamoxifen—Thrombocytopenia—Fluorouracil—skin cancer	0.000164	0.000785	CcSEcCtD
Tamoxifen—Visual impairment—Docetaxel—skin cancer	0.000164	0.000785	CcSEcCtD
Tamoxifen—Paraesthesia—Temozolomide—skin cancer	0.000164	0.000781	CcSEcCtD
Tamoxifen—Dyspnoea—Temozolomide—skin cancer	0.000163	0.000776	CcSEcCtD
Tamoxifen—Erythema multiforme—Docetaxel—skin cancer	0.000161	0.00077	CcSEcCtD
Tamoxifen—Dyspepsia—Temozolomide—skin cancer	0.00016	0.000766	CcSEcCtD
Tamoxifen—Anorexia—Fluorouracil—skin cancer	0.00016	0.000764	CcSEcCtD
Tamoxifen—Abdominal pain—Dactinomycin—skin cancer	0.000159	0.00076	CcSEcCtD
Tamoxifen—Hypersensitivity—Bleomycin—skin cancer	0.000159	0.00076	CcSEcCtD
Tamoxifen—Decreased appetite—Temozolomide—skin cancer	0.000158	0.000756	CcSEcCtD
Tamoxifen—Flushing—Docetaxel—skin cancer	0.000158	0.000756	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Temozolomide—skin cancer	0.000157	0.000751	CcSEcCtD
Tamoxifen—Fatigue—Temozolomide—skin cancer	0.000157	0.00075	CcSEcCtD
Tamoxifen—Pain—Temozolomide—skin cancer	0.000156	0.000744	CcSEcCtD
Tamoxifen—Constipation—Temozolomide—skin cancer	0.000156	0.000744	CcSEcCtD
Tamoxifen—Asthenia—Bleomycin—skin cancer	0.000155	0.00074	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000153	0.00073	CcSEcCtD
Tamoxifen—ABCB1—lymphoid tissue—skin cancer	0.000153	0.00252	CbGeAlD
Tamoxifen—Pruritus—Bleomycin—skin cancer	0.000153	0.00073	CcSEcCtD
Tamoxifen—Arrhythmia—Docetaxel—skin cancer	0.000152	0.000728	CcSEcCtD
Tamoxifen—Insomnia—Fluorouracil—skin cancer	0.000152	0.000725	CcSEcCtD
Tamoxifen—Paraesthesia—Fluorouracil—skin cancer	0.000151	0.00072	CcSEcCtD
Tamoxifen—Alopecia—Docetaxel—skin cancer	0.000151	0.00072	CcSEcCtD
Tamoxifen—Dyspnoea—Fluorouracil—skin cancer	0.00015	0.000715	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Temozolomide—skin cancer	0.000149	0.000712	CcSEcCtD
Tamoxifen—Erythema—Docetaxel—skin cancer	0.000149	0.000709	CcSEcCtD
Tamoxifen—Hypersensitivity—Dactinomycin—skin cancer	0.000149	0.000709	CcSEcCtD
Tamoxifen—Dyspepsia—Fluorouracil—skin cancer	0.000148	0.000706	CcSEcCtD
Tamoxifen—ABCB1—female reproductive system—skin cancer	0.000148	0.00243	CbGeAlD
Tamoxifen—Decreased appetite—Fluorouracil—skin cancer	0.000146	0.000697	CcSEcCtD
Tamoxifen—Dysgeusia—Docetaxel—skin cancer	0.000145	0.000694	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000145	0.000692	CcSEcCtD
Tamoxifen—Urticaria—Temozolomide—skin cancer	0.000145	0.000691	CcSEcCtD
Tamoxifen—Asthenia—Dactinomycin—skin cancer	0.000145	0.00069	CcSEcCtD
Tamoxifen—Abdominal pain—Temozolomide—skin cancer	0.000144	0.000688	CcSEcCtD
Tamoxifen—Back pain—Docetaxel—skin cancer	0.000144	0.000686	CcSEcCtD
Tamoxifen—Pain—Fluorouracil—skin cancer	0.000144	0.000686	CcSEcCtD
Tamoxifen—Muscle spasms—Docetaxel—skin cancer	0.000143	0.000682	CcSEcCtD
Tamoxifen—Diarrhoea—Dactinomycin—skin cancer	0.000138	0.000658	CcSEcCtD
Tamoxifen—Vomiting—Bleomycin—skin cancer	0.000137	0.000656	CcSEcCtD
Tamoxifen—Anaemia—Docetaxel—skin cancer	0.000137	0.000655	CcSEcCtD
Tamoxifen—Rash—Bleomycin—skin cancer	0.000136	0.00065	CcSEcCtD
Tamoxifen—Dermatitis—Bleomycin—skin cancer	0.000136	0.00065	CcSEcCtD
Tamoxifen—Hypersensitivity—Temozolomide—skin cancer	0.000134	0.000641	CcSEcCtD
Tamoxifen—Urticaria—Fluorouracil—skin cancer	0.000133	0.000637	CcSEcCtD
Tamoxifen—Leukopenia—Docetaxel—skin cancer	0.000133	0.000635	CcSEcCtD
Tamoxifen—Asthenia—Temozolomide—skin cancer	0.000131	0.000624	CcSEcCtD
Tamoxifen—Cough—Docetaxel—skin cancer	0.00013	0.000619	CcSEcCtD
Tamoxifen—Pruritus—Temozolomide—skin cancer	0.000129	0.000616	CcSEcCtD
Tamoxifen—Nausea—Bleomycin—skin cancer	0.000128	0.000613	CcSEcCtD
Tamoxifen—Hypertension—Docetaxel—skin cancer	0.000128	0.000612	CcSEcCtD
Tamoxifen—Vomiting—Dactinomycin—skin cancer	0.000128	0.000612	CcSEcCtD
Tamoxifen—Rash—Dactinomycin—skin cancer	0.000127	0.000607	CcSEcCtD
Tamoxifen—Myalgia—Docetaxel—skin cancer	0.000126	0.000604	CcSEcCtD
Tamoxifen—Arthralgia—Docetaxel—skin cancer	0.000126	0.000604	CcSEcCtD
Tamoxifen—Chest pain—Docetaxel—skin cancer	0.000126	0.000604	CcSEcCtD
Tamoxifen—Diarrhoea—Temozolomide—skin cancer	0.000125	0.000595	CcSEcCtD
Tamoxifen—Hypersensitivity—Fluorouracil—skin cancer	0.000124	0.000591	CcSEcCtD
Tamoxifen—Dry mouth—Docetaxel—skin cancer	0.000124	0.00059	CcSEcCtD
Tamoxifen—ABCB1—head—skin cancer	0.000123	0.00203	CbGeAlD
Tamoxifen—Oedema—Docetaxel—skin cancer	0.000121	0.000579	CcSEcCtD
Tamoxifen—Dizziness—Temozolomide—skin cancer	0.000121	0.000575	CcSEcCtD
Tamoxifen—Infection—Docetaxel—skin cancer	0.00012	0.000575	CcSEcCtD
Tamoxifen—Nausea—Dactinomycin—skin cancer	0.00012	0.000571	CcSEcCtD
Tamoxifen—Pruritus—Fluorouracil—skin cancer	0.000119	0.000567	CcSEcCtD
Tamoxifen—Thrombocytopenia—Docetaxel—skin cancer	0.000119	0.000567	CcSEcCtD
Tamoxifen—Vomiting—Temozolomide—skin cancer	0.000116	0.000553	CcSEcCtD
Tamoxifen—Anorexia—Docetaxel—skin cancer	0.000116	0.000552	CcSEcCtD
Tamoxifen—Rash—Temozolomide—skin cancer	0.000115	0.000549	CcSEcCtD
Tamoxifen—Diarrhoea—Fluorouracil—skin cancer	0.000115	0.000549	CcSEcCtD
Tamoxifen—Dermatitis—Temozolomide—skin cancer	0.000115	0.000548	CcSEcCtD
Tamoxifen—Headache—Temozolomide—skin cancer	0.000114	0.000545	CcSEcCtD
Tamoxifen—Dizziness—Fluorouracil—skin cancer	0.000111	0.00053	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00011	0.000527	CcSEcCtD
Tamoxifen—Insomnia—Docetaxel—skin cancer	0.00011	0.000523	CcSEcCtD
Tamoxifen—Paraesthesia—Docetaxel—skin cancer	0.000109	0.00052	CcSEcCtD
Tamoxifen—Nausea—Temozolomide—skin cancer	0.000108	0.000517	CcSEcCtD
Tamoxifen—Dyspnoea—Docetaxel—skin cancer	0.000108	0.000516	CcSEcCtD
Tamoxifen—Vomiting—Fluorouracil—skin cancer	0.000107	0.00051	CcSEcCtD
Tamoxifen—Dyspepsia—Docetaxel—skin cancer	0.000107	0.000509	CcSEcCtD
Tamoxifen—Rash—Fluorouracil—skin cancer	0.000106	0.000505	CcSEcCtD
Tamoxifen—Dermatitis—Fluorouracil—skin cancer	0.000106	0.000505	CcSEcCtD
Tamoxifen—Decreased appetite—Docetaxel—skin cancer	0.000105	0.000503	CcSEcCtD
Tamoxifen—Headache—Fluorouracil—skin cancer	0.000105	0.000502	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Docetaxel—skin cancer	0.000105	0.0005	CcSEcCtD
Tamoxifen—Fatigue—Docetaxel—skin cancer	0.000105	0.000499	CcSEcCtD
Tamoxifen—Pain—Docetaxel—skin cancer	0.000104	0.000495	CcSEcCtD
Tamoxifen—Constipation—Docetaxel—skin cancer	0.000104	0.000495	CcSEcCtD
Tamoxifen—Nausea—Fluorouracil—skin cancer	9.98e-05	0.000476	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Docetaxel—skin cancer	9.91e-05	0.000473	CcSEcCtD
Tamoxifen—Abdominal pain—Docetaxel—skin cancer	9.58e-05	0.000457	CcSEcCtD
Tamoxifen—Hypersensitivity—Docetaxel—skin cancer	8.93e-05	0.000426	CcSEcCtD
Tamoxifen—Asthenia—Docetaxel—skin cancer	8.7e-05	0.000415	CcSEcCtD
Tamoxifen—ABCB1—lymph node—skin cancer	8.63e-05	0.00142	CbGeAlD
Tamoxifen—Pruritus—Docetaxel—skin cancer	8.58e-05	0.000409	CcSEcCtD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—XRCC3—skin cancer	8.41e-05	0.00674	CbGpPWpGaD
Tamoxifen—CES1—E2F transcription factor network—CDKN2A—skin cancer	8.39e-05	0.00673	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	8.38e-05	0.00671	CbGpPWpGaD
Tamoxifen—Diarrhoea—Docetaxel—skin cancer	8.3e-05	0.000396	CcSEcCtD
Tamoxifen—Dizziness—Docetaxel—skin cancer	8.02e-05	0.000383	CcSEcCtD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	7.94e-05	0.00636	CbGpPWpGaD
Tamoxifen—CYP1A1—PPARA activates gene expression—PLIN2—skin cancer	7.94e-05	0.00636	CbGpPWpGaD
Tamoxifen—ESR2—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	7.77e-05	0.00623	CbGpPWpGaD
Tamoxifen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	7.77e-05	0.00623	CbGpPWpGaD
Tamoxifen—Vomiting—Docetaxel—skin cancer	7.71e-05	0.000368	CcSEcCtD
Tamoxifen—Rash—Docetaxel—skin cancer	7.64e-05	0.000365	CcSEcCtD
Tamoxifen—Dermatitis—Docetaxel—skin cancer	7.64e-05	0.000365	CcSEcCtD
Tamoxifen—Headache—Docetaxel—skin cancer	7.6e-05	0.000362	CcSEcCtD
Tamoxifen—Nausea—Docetaxel—skin cancer	7.2e-05	0.000344	CcSEcCtD
Tamoxifen—ESR1—FOXM1 transcription factor network—CDK4—skin cancer	6.92e-05	0.00554	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO4—skin cancer	6.84e-05	0.00548	CbGpPWpGaD
Tamoxifen—ESR2—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	6.69e-05	0.00536	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—MSH2—skin cancer	6.06e-05	0.00485	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PLIN2—skin cancer	5.9e-05	0.00472	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PLIN2—skin cancer	5.79e-05	0.00464	CbGpPWpGaD
Tamoxifen—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—skin cancer	5.72e-05	0.00458	CbGpPWpGaD
Tamoxifen—ESR2—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	5.69e-05	0.00456	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PLIN2—skin cancer	5.59e-05	0.00448	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MSH2—skin cancer	5.42e-05	0.00434	CbGpPWpGaD
Tamoxifen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	5.36e-05	0.00429	CbGpPWpGaD
Tamoxifen—ESR1—FOXM1 transcription factor network—CDKN2A—skin cancer	5.29e-05	0.00424	CbGpPWpGaD
Tamoxifen—ESR1—ATF-2 transcription factor network—CDK4—skin cancer	5.27e-05	0.00422	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	5.27e-05	0.00422	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—TERT—skin cancer	5.26e-05	0.00421	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	4.94e-05	0.00396	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PLIN2—skin cancer	4.81e-05	0.00385	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	4.77e-05	0.00382	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—CSPG4—skin cancer	4.75e-05	0.00381	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—CSPG4—skin cancer	4.66e-05	0.00374	CbGpPWpGaD
Tamoxifen—CYP1B1—Arachidonic acid metabolism—PTGS2—skin cancer	4.62e-05	0.00371	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	4.6e-05	0.00368	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—CSPG4—skin cancer	4.51e-05	0.00361	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PLIN2—skin cancer	4.47e-05	0.00358	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	4.22e-05	0.00338	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—FOXO4—skin cancer	4.13e-05	0.00331	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—skin cancer	4.09e-05	0.00328	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	4.08e-05	0.00327	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	4e-05	0.00321	CbGpPWpGaD
Tamoxifen—ESR1—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	3.92e-05	0.00314	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—CSPG4—skin cancer	3.87e-05	0.0031	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	3.85e-05	0.00308	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CSPG4—skin cancer	3.6e-05	0.00289	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.6e-05	0.00288	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	3.58e-05	0.00287	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—CDKN2A—skin cancer	3.51e-05	0.00281	CbGpPWpGaD
Tamoxifen—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	3.49e-05	0.0028	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.46e-05	0.00277	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PLIN2—skin cancer	3.44e-05	0.00275	CbGpPWpGaD
Tamoxifen—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	3.4e-05	0.00273	CbGpPWpGaD
Tamoxifen—ESR1—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	3.37e-05	0.0027	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	3.31e-05	0.00265	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.27e-05	0.00262	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—ENO2—skin cancer	3.23e-05	0.00259	CbGpPWpGaD
Tamoxifen—CYP2A6—Fluoropyrimidine Activity—TP53—skin cancer	3.17e-05	0.00254	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—ENO2—skin cancer	3.17e-05	0.00254	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	3.08e-05	0.00247	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—ENO2—skin cancer	3.06e-05	0.00245	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	3.04e-05	0.00244	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.92e-05	0.00234	CbGpPWpGaD
Tamoxifen—ESR1—LKB1 signaling events—TP53—skin cancer	2.89e-05	0.00231	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PLIN2—skin cancer	2.88e-05	0.00231	CbGpPWpGaD
Tamoxifen—ESR1—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	2.87e-05	0.0023	CbGpPWpGaD
Tamoxifen—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	2.85e-05	0.00228	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	2.85e-05	0.00228	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.84e-05	0.00228	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.81e-05	0.00225	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CDK4—skin cancer	2.78e-05	0.00222	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CSPG4—skin cancer	2.77e-05	0.00222	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—ENO2—skin cancer	2.63e-05	0.00211	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.62e-05	0.0021	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RHOU—skin cancer	2.61e-05	0.00209	CbGpPWpGaD
Tamoxifen—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	2.61e-05	0.00209	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.53e-05	0.00202	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CDK4—skin cancer	2.48e-05	0.00199	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—BRAF—skin cancer	2.46e-05	0.00197	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—ENO2—skin cancer	2.45e-05	0.00196	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.39e-05	0.00192	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.37e-05	0.0019	CbGpPWpGaD
Tamoxifen—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	2.33e-05	0.00187	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CSPG4—skin cancer	2.32e-05	0.00186	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—IL6—skin cancer	2.26e-05	0.00181	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.24e-05	0.00179	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—BRAF—skin cancer	2.2e-05	0.00176	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.13e-05	0.00171	CbGpPWpGaD
Tamoxifen—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	2.12e-05	0.0017	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PLIN2—skin cancer	2.12e-05	0.0017	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.12e-05	0.0017	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.06e-05	0.00165	CbGpPWpGaD
Tamoxifen—ESR1—ATF-2 transcription factor network—IL6—skin cancer	2.05e-05	0.00164	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.04e-05	0.00163	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.96e-05	0.00157	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TP53—skin cancer	1.95e-05	0.00157	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.95e-05	0.00157	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	1.94e-05	0.00156	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.91e-05	0.00153	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ENO2—skin cancer	1.88e-05	0.00151	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—ERCC2—skin cancer	1.88e-05	0.0015	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—IL6—skin cancer	1.87e-05	0.0015	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—ERCC2—skin cancer	1.84e-05	0.00148	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—ERCC2—skin cancer	1.83e-05	0.00147	CbGpPWpGaD
Tamoxifen—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	1.82e-05	0.00145	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—IL6—skin cancer	1.79e-05	0.00143	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—ERCC2—skin cancer	1.78e-05	0.00143	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—HRAS—skin cancer	1.77e-05	0.00142	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.75e-05	0.0014	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.74e-05	0.00139	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.73e-05	0.00139	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CSPG4—skin cancer	1.71e-05	0.00137	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PLIN2—skin cancer	1.6e-05	0.00128	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.59e-05	0.00128	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ENO2—skin cancer	1.58e-05	0.00126	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PLIN2—skin cancer	1.54e-05	0.00124	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.54e-05	0.00123	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—ERCC2—skin cancer	1.53e-05	0.00123	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	1.51e-05	0.00121	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.47e-05	0.00118	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—ERCC2—skin cancer	1.42e-05	0.00114	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PLIN2—skin cancer	1.4e-05	0.00112	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PLIN2—skin cancer	1.39e-05	0.00111	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—NRAS—skin cancer	1.37e-05	0.0011	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.36e-05	0.00109	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.33e-05	0.00106	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	1.3e-05	0.00104	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CSPG4—skin cancer	1.29e-05	0.00103	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTCH2—skin cancer	1.28e-05	0.00102	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PLIN2—skin cancer	1.27e-05	0.00102	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CSPG4—skin cancer	1.24e-05	0.000996	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.19e-05	0.000953	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—KRAS—skin cancer	1.18e-05	0.000948	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—skin cancer	1.18e-05	0.000946	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—ERCC2—skin cancer	1.16e-05	0.000933	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ENO2—skin cancer	1.16e-05	0.000932	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CSPG4—skin cancer	1.13e-05	0.000906	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PTGS2—skin cancer	1.13e-05	0.000902	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CSPG4—skin cancer	1.12e-05	0.000898	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.1e-05	0.000885	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PTGS2—skin cancer	1.1e-05	0.000885	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ERCC2—skin cancer	1.09e-05	0.000876	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.09e-05	0.000873	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PTGS2—skin cancer	1.07e-05	0.000855	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—skin cancer	1.06e-05	0.000847	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PLIN2—skin cancer	1.03e-05	0.000824	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CSPG4—skin cancer	1.03e-05	0.000823	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PLIN2—skin cancer	1.01e-05	0.000807	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—HRAS—skin cancer	1.01e-05	0.000806	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PLIN2—skin cancer	1.01e-05	0.000806	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	9.85e-06	0.000789	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GLI2—skin cancer	9.66e-06	0.000774	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—IL6—skin cancer	9.62e-06	0.000771	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PLIN2—skin cancer	9.5e-06	0.000761	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MC1R—skin cancer	9.22e-06	0.000739	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTGS2—skin cancer	9.17e-06	0.000735	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ERCC2—skin cancer	9.16e-06	0.000734	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.1e-06	0.000729	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GLI1—skin cancer	9.09e-06	0.000728	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ENO2—skin cancer	8.78e-06	0.000703	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	8.76e-06	0.000702	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PLIN2—skin cancer	8.71e-06	0.000698	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SUFU—skin cancer	8.61e-06	0.00069	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTGS2—skin cancer	8.53e-06	0.000683	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ENO2—skin cancer	8.45e-06	0.000677	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CSPG4—skin cancer	8.29e-06	0.000664	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CSPG4—skin cancer	8.12e-06	0.000651	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CSPG4—skin cancer	8.1e-06	0.000649	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	7.78e-06	0.000624	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PLIN2—skin cancer	7.77e-06	0.000623	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ENO2—skin cancer	7.69e-06	0.000616	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CSPG4—skin cancer	7.66e-06	0.000613	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ENO2—skin cancer	7.62e-06	0.000611	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PLIN2—skin cancer	7.59e-06	0.000608	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PLIN2—skin cancer	7.15e-06	0.000573	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PLIN2—skin cancer	7.09e-06	0.000568	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CSPG4—skin cancer	7.02e-06	0.000562	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ENO2—skin cancer	6.98e-06	0.00056	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.86e-06	0.00055	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ERCC2—skin cancer	6.76e-06	0.000541	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.61e-06	0.00053	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SHH—skin cancer	6.57e-06	0.000526	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTGS2—skin cancer	6.56e-06	0.000525	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RASA1—skin cancer	6.53e-06	0.000523	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CSPG4—skin cancer	6.27e-06	0.000502	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTCH1—skin cancer	6.23e-06	0.000499	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SMO—skin cancer	6.23e-06	0.000499	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CSPG4—skin cancer	6.11e-06	0.00049	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTGER4—skin cancer	6.06e-06	0.000486	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PLIN2—skin cancer	6.06e-06	0.000485	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—ERCC2—skin cancer	5.87e-06	0.00047	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CSPG4—skin cancer	5.76e-06	0.000462	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CSPG4—skin cancer	5.71e-06	0.000458	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ENO2—skin cancer	5.64e-06	0.000452	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ENO2—skin cancer	5.52e-06	0.000442	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ENO2—skin cancer	5.51e-06	0.000441	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTGS2—skin cancer	5.49e-06	0.00044	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FOXO4—skin cancer	5.36e-06	0.000429	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.21e-06	0.000418	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ENO2—skin cancer	5.2e-06	0.000417	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ERCC2—skin cancer	5.1e-06	0.000408	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ERCC2—skin cancer	4.91e-06	0.000393	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CSPG4—skin cancer	4.88e-06	0.000391	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ENO2—skin cancer	4.77e-06	0.000382	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLIN2—skin cancer	4.67e-06	0.000375	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.63e-06	0.000371	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ERCC2—skin cancer	4.47e-06	0.000358	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ERCC2—skin cancer	4.43e-06	0.000355	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ENO2—skin cancer	4.26e-06	0.000341	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ENO2—skin cancer	4.16e-06	0.000333	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.07e-06	0.000326	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ERCC2—skin cancer	4.06e-06	0.000325	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—skin cancer	4.05e-06	0.000325	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ENO2—skin cancer	3.92e-06	0.000314	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ENO2—skin cancer	3.88e-06	0.000311	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CSPG4—skin cancer	3.77e-06	0.000302	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.73e-06	0.000299	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TERT—skin cancer	3.58e-06	0.000287	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.33e-06	0.000267	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ENO2—skin cancer	3.32e-06	0.000266	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ERCC2—skin cancer	3.27e-06	0.000262	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ERCC2—skin cancer	3.21e-06	0.000257	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ERCC2—skin cancer	3.2e-06	0.000256	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—skin cancer	3.06e-06	0.000245	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.04e-06	0.000243	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ERCC2—skin cancer	3.02e-06	0.000242	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—skin cancer	2.94e-06	0.000236	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—skin cancer	2.83e-06	0.000227	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ERCC2—skin cancer	2.77e-06	0.000222	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—skin cancer	2.68e-06	0.000215	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—skin cancer	2.65e-06	0.000213	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.6e-06	0.000208	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO2—skin cancer	2.56e-06	0.000205	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ERCC2—skin cancer	2.47e-06	0.000198	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—skin cancer	2.43e-06	0.000195	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ERCC2—skin cancer	2.41e-06	0.000193	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ERCC2—skin cancer	2.28e-06	0.000182	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ERCC2—skin cancer	2.26e-06	0.000181	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—skin cancer	1.96e-06	0.000157	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ERCC2—skin cancer	1.93e-06	0.000154	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—skin cancer	1.92e-06	0.000154	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—skin cancer	1.92e-06	0.000154	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—skin cancer	1.81e-06	0.000145	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—skin cancer	1.78e-06	0.000143	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—skin cancer	1.66e-06	0.000133	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—skin cancer	1.53e-06	0.000123	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ERCC2—skin cancer	1.49e-06	0.000119	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—skin cancer	1.48e-06	0.000119	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—skin cancer	1.45e-06	0.000116	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—skin cancer	1.36e-06	0.000109	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—skin cancer	1.36e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—skin cancer	1.35e-06	0.000108	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—skin cancer	1.3e-06	0.000104	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—skin cancer	1.25e-06	9.99e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—skin cancer	1.16e-06	9.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—skin cancer	8.92e-07	7.15e-05	CbGpPWpGaD
